EDC for dermatology clinical trials: skin and dermatologic endpoints, ePRO, and 21 CFR Part 11–aligned controls.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
Overview
Dermatology clinical trials evaluate treatments for skin conditions with clinician-assessed and often patient-reported endpoints. Your EDC must support consent, CRFs, ePRO for symptom and QoL instruments, and full auditability for regulatory and publication use. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so dermatology study teams can capture clinical and PRO data with one audit trail.
Dermatology studies often use validated scales, photo documentation, and patient-reported outcomes. You need one system that handles consent, CRFs, and ePRO with the same audit trail and access controls. Standalone ePRO systems often don’t integrate with EDC. Capture integrates ePRO with EDC and eConsent so dermatology endpoints are captured with the same controls and audit history as clinical data.
FAQ
Explore the platform with a free sandbox. No sales call required.